Postcoital contraception. Has its day come?
Although postcoital contraception might aid in reducing the occurrence of some unintended pregnancies, it is seldom used. This review summarizes the development of postcoital methods, focusing on the Yuzpe regimen, the most widely used emergency contraceptive in the United States. The article discusses its mechanism of action, safety, side effects, and effectiveness. Reasons for its limited use are discussed, as are recent findings that RU 486 may be a superior postcoital agent. Finally, a protocol for integrating the Yuzpe method into nurse-midwifery practice is presented.
Narrigan
D
D
Vanderbilt University School of Nursing.
D002985:Clinical Protocols; D003282:Contraceptives, Postcoital, Hormonal / Q000008:administration & dosage / Q000494:pharmacology*; D003613:Danazol / Q000494:pharmacology; D004334:Drug Administration Schedule; D004997:Ethinyl Estradiol / Q000494:pharmacology; D019304:Ethinyl Estradiol-Norgestrel Combination; D005260:Female; D006801:Humans; D015735:Mifepristone / Q000494:pharmacology; D009644:Norgestrel / Q000494:pharmacology; D009721:Nurse Midwives
D003282:Contraceptives, Postcoital, Hormonal; D015735:Mifepristone; D009644:Norgestrel; D004997:Ethinyl Estradiol; D019304:Ethinyl Estradiol-Norgestrel Combination; D003613:Danazol